SARS-CoV-2 Virology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yijia, Li, Jonathan Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802625/
https://www.ncbi.nlm.nih.gov/pubmed/35636899
http://dx.doi.org/10.1016/j.idc.2022.01.004
_version_ 1784642710696624128
author Li, Yijia
Li, Jonathan Z.
author_facet Li, Yijia
Li, Jonathan Z.
author_sort Li, Yijia
collection PubMed
description Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic. In this review, the authors focus on the genomic features of SARS-CoV-2, its intrahost and interhost evolution, viral dynamics in respiratory tract, and systemic dissemination.
format Online
Article
Text
id pubmed-8802625
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88026252022-01-31 SARS-CoV-2 Virology Li, Yijia Li, Jonathan Z. Infect Dis Clin North Am Article Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in 2020 and has led to an unprecedented global pandemic. Understanding the virology behind SARS-CoV-2 infection has provided key insights into our efforts to develop antiviral agents and control the COVID-19 pandemic. In this review, the authors focus on the genomic features of SARS-CoV-2, its intrahost and interhost evolution, viral dynamics in respiratory tract, and systemic dissemination. Elsevier Inc. 2022-06 2022-01-31 /pmc/articles/PMC8802625/ /pubmed/35636899 http://dx.doi.org/10.1016/j.idc.2022.01.004 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Li, Yijia
Li, Jonathan Z.
SARS-CoV-2 Virology
title SARS-CoV-2 Virology
title_full SARS-CoV-2 Virology
title_fullStr SARS-CoV-2 Virology
title_full_unstemmed SARS-CoV-2 Virology
title_short SARS-CoV-2 Virology
title_sort sars-cov-2 virology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802625/
https://www.ncbi.nlm.nih.gov/pubmed/35636899
http://dx.doi.org/10.1016/j.idc.2022.01.004
work_keys_str_mv AT liyijia sarscov2virology
AT lijonathanz sarscov2virology

Ejemplares similares